BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36245369)

  • 1. Prognostic value of Talin-1 in renal cell carcinoma and its association with B7-H3.
    Saeednejad Zanjani L; Vafaei S; Abolhasani M; Fattahi F; Madjd Z
    Cancer Biomark; 2022; 35(3):269-292. PubMed ID: 36245369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic expression of B7-H3 and membranous EpCAM expression are associated with higher grade and survival outcomes in patients with clear cell renal cell carcinoma.
    Saeednejad Zanjani L; Madjd Z; Axcrona U; Abolhasani M; Rasti A; Asgari M; Fodstad Ø; Andersson Y
    Ann Diagn Pathol; 2020 Jun; 46():151483. PubMed ID: 32143173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma.
    Crispen PL; Sheinin Y; Roth TJ; Lohse CM; Kuntz SM; Frigola X; Thompson RH; Boorjian SA; Dong H; Leibovich BC; Blute ML; Kwon ED
    Clin Cancer Res; 2008 Aug; 14(16):5150-7. PubMed ID: 18694993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma.
    Saeednejad Zanjani L; Madjd Z; Abolhasani M; Andersson Y; Rasti A; Shariftabrizi A; Asgari M
    Exp Mol Pathol; 2017 Oct; 103(2):218-228. PubMed ID: 29050853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of cytoplasmic dynamin 2 is associated with worse outcomes in patients with clear cell renal cell carcinoma.
    Safaei S; Sajed R; Saeednejad Zanjani L; Rahimi M; Fattahi F; Ensieh Kazemi-Sefat G; Razmi M; Dorafshan S; Eini L; Madjd Z; Ghods R
    Cancer Biomark; 2022; 35(1):27-45. PubMed ID: 35662107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.
    Rasti A; Madjd Z; Abolhasani M; Mehrazma M; Janani L; Saeednejad Zanjani L; Asgari M
    Clin Exp Med; 2018 May; 18(2):177-190. PubMed ID: 29204790
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S
    DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human telomerase reverse transcriptase protein expression predicts tumour aggressiveness and survival in patients with clear cell renal cell carcinoma.
    Saeednejad Zanjani L; Madjd Z; Abolhasani M; Rasti A; Shariftabrizi A; Mehrazma M; Fodstad Ø; Asgari M
    Pathology; 2019 Jan; 51(1):21-31. PubMed ID: 30466948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas.
    Rasti A; Mehrazma M; Madjd Z; Abolhasani M; Saeednejad Zanjani L; Asgari M
    Sci Rep; 2018 Aug; 8(1):11739. PubMed ID: 30082842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
    Peng Y; Greenland NY; Lang UE; Stohr BA
    Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibronectin enhances tumor metastasis through B7-H3 in clear cell renal cell carcinoma.
    Xie J; Sun M; Zhang D; Chen C; Lin S; Zhang G
    FEBS Open Bio; 2021 Nov; 11(11):2977-2987. PubMed ID: 34431237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
    Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
    Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Identification of Zinc-Finger Protein 433 as a Possible Prognostic Biomarker for Clear-Cell Renal Cell Carcinoma.
    Heyliger SO; Soliman KFA; Saulsbury MD; Reams RR
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression.
    Jung M; Lee C; Park JH; Moon KC
    Urol Oncol; 2019 Nov; 37(11):812.e9-812.e16. PubMed ID: 31421995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
    Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
    BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capn4 contributes to tumor invasion and metastasis in clear cell renal cell carcinoma cells via modulating talin-focal adhesion kinase signaling pathway.
    Zhuang Q; Luo W; Zhang M; Fan M; Lu H; Xu R; He X
    Acta Biochim Biophys Sin (Shanghai); 2018 May; 50(5):465-472. PubMed ID: 29648579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma.
    Pan Q; Cheng G; Liu Y; Xu T; Zhang H; Li B
    Int J Oncol; 2020 May; 56(5):1101-1114. PubMed ID: 32319572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
    Xu WH; Shi SN; Wang J; Xu Y; Tian X; Wan FN; Cao DL; Qu YY; Zhang HL; Ye DW
    Med Sci Monit; 2019 Dec; 25():9458-9470. PubMed ID: 31825950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and significance of B7-H3 and Tie-2 in the tumor vasculature of clear cell renal carcinoma.
    Zhang X; Ji J; Zhang G; Fang C; Jiang F; Ma S; Hou J
    Onco Targets Ther; 2017; 10():5417-5424. PubMed ID: 29180874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.